Programmed death-1 receptor and interleukin-10 in liver transplant recipients at high risk for late cytomegalovirus disease

scientific article

Programmed death-1 receptor and interleukin-10 in liver transplant recipients at high risk for late cytomegalovirus disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1399-3062.2009.00489.X
P932PMC publication ID2950160
P698PubMed publication ID20070620
P5875ResearchGate publication ID41012045

P50authorDon J. DiamondQ37374385
Simon F LaceyQ56978267
P2093author name stringW Zhou
A Krishnan
A P Limaye
C La Rosa
P2860cites workPotent immunosuppressive activities of cytomegalovirus-encoded interleukin-10Q24540441
Functional comparison of T cells recognizing cytomegalovirus pp65 and intermediate-early antigen polypeptides in hematopoietic stem-cell transplant and solid organ transplant recipientsQ33260989
Longitudinal assessment of cytomegalovirus (CMV)-specific immune responses in liver transplant recipients at high risk for late CMV diseaseQ33270851
Dysregulated cytokine responses during cytomegalovirus infection in renal transplant recipientsQ33353651
PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infectionQ34570624
PD-1 expression and IL-2 loss of cytomegalovirus- specific T cells correlates with viremia and reversible functional anergyQ34592551
Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificitiesQ35850673
Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cellsQ36403419
IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infectionQ36509838
Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipientsQ36728782
IL-10, T cell exhaustion and viral persistenceQ36750429
IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infectionQ37068471
Late-onset cytomegalovirus disease in liver transplant recipients despite antiviral prophylaxisQ45153747
Programmed death-1 expression in liver transplant recipients as a prognostic indicator of cytomegalovirus disease.Q45979494
Population coverage by HLA class-I restricted cytotoxic T-lymphocyte epitopes.Q47581560
Differences in CMV-Specific T-Cell Levels and Long-Term Susceptibility to CMV Infection after Kidney, Heart and Lung TransplantationQ60615092
Immunologic predictors of late cytomegalovirus disease after solid organ transplantation--an elusive goal?Q79687916
Impact of cytomegalovirus in organ transplant recipients in the era of antiviral prophylaxisQ79775594
Monitoring of human cytomegalovirus-specific CD4 and CD8 T-cell immunity in patients receiving solid organ transplantationQ80061563
Inconsistent responses of cytomegalovirus-specific T cells to pp65 and IE-1 versus infected dendritic cells in organ transplant recipientsQ80583323
P433issue4
P921main subjectCytomegalovirusQ6946
interleukinsQ194908
P304page(s)363-370
P577publication date2010-01-11
P1433published inTransplant Infectious DiseaseQ15749562
P1476titleProgrammed death-1 receptor and interleukin-10 in liver transplant recipients at high risk for late cytomegalovirus disease
P478volume12

Reverse relations

cites work (P2860)
Q36037639CD28 family and chronic rejection: "to belatacept...And beyond!".
Q26998832Clinical immune-monitoring strategies for predicting infection risk in solid organ transplantation
Q37188559Combined Detection of Serum IL-10, IL-17, and CXCL10 Predicts Acute Rejection Following Adult Liver Transplantation
Q37359332Cytomegalovirus infections in solid organ transplantation: a review
Q34616701Detection and preliminary characterization of CD8+T lymphocytes specific for Wilms' tumor antigen in patients with non-Hodgkin lymphoma.
Q35134243Effects of donor/recipient human leukocyte antigen mismatch on human cytomegalovirus replication following liver transplantation
Q42645889Ex vivo detection of CD8 T cells specific for H-Y minor histocompatibility antigens in allogeneic hematopoietic stem cell transplant recipients
Q38011227Immune response to CMV in solid organ transplant recipients: current concepts and future directions
Q44050947Immunological insights into the pathogenesis of active CMV infection in non-immunosuppressed critically ill patients
Q47585004Impact of donor and recipient human cytomegalovirus status on kidney transplantation.
Q42244580Increased levels of PD-1 expression on CD8 T cells in patients post-renal transplant irrespective of chronic high EBV viral load.
Q36389162Plasma IL-10 Levels to Guide Antiviral Prophylaxis Prevention of Late-Onset Cytomegalovirus Disease, in High Risk Solid Kidney and Liver Transplant Recipients
Q33932079Primary response against cytomegalovirus during antiviral prophylaxis with valganciclovir, in solid organ transplant recipients
Q34164098Programmed death-1/B7-H1 negative costimulation protects mouse liver against ischemia and reperfusion injury
Q90615815Rapid Acquisition of Cytomegalovirus-Specific T Cells with a Differentiated Phenotype, in Nonviremic Hematopoietic Stem Transplant Recipients Vaccinated with CMVPepVax
Q36476646Role of TLR2-dependent IL-10 production in the inhibition of the initial IFN-γ T cell response to Porphyromonas gingivalis.
Q36517022The immune response to human CMV
Q84028052[Immunological monitoring strategies for cytomegalovirus infection. Immune-based therapies]

Search more.